TrialNature communications2026
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial.
Valentina O Puntmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.